Active: Benign prostatic hyperplasia Clear all

GWAS 2020-11-20

Genome-wide association study identifies a role for the progesterone receptor in benign prostatic hyperplasia risk.

Li W, Klein RJ

Prostate Cancer Prostatic Dis

Benign prostatic hyperplasia (BPH) is common noncancerous prostate enlargement, which is usually ass...

Benign prostatic hyperplasia

Replicated

173692

Participants

N/A

Studies

Details PubMed

GWAS 2019-04-15

Heritability and genome-wide association study of benign prostatic hyperplasia (BPH) in the eMERGE network.

Hellwege JN, Stallings S et al.

Sci Rep

Benign prostatic hyperplasia (BPH) results in a significant public health burden due to the morbidit...

Benign prostatic hyperplasia

10419

Participants

N/A

Studies

Details PubMed

GWAS 2018-11-08

Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA.

Gudmundsson J, Sigurdsson JK et al.

Nat Commun

Benign prostatic hyperplasia and associated lower urinary tract symptoms (BPH/LUTS) are common condi...

Benign prostatic hyperplasia and lower urinary tract symptoms

301162

Participants

N/A

Studies

Details PubMed

GWAS 2017-06-28

A genetic variant near GATA3 implicated in inherited susceptibility and etiology of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS).

Na R, Helfand BT et al.

Prostate

Benign prostatic hyperplasia (BPH) and associated lower urinary tract symptoms (LUTS) are common con...

Benign prostatic hyperplasia and/or lower urinary tract symptoms

Replicated

5079

Participants

N/A

Studies

Details PubMed

GWAS 2014-11-27

Genetic variants at 1q32.1, 10q11.2 and 19q13.41 are associated with prostate-specific antigen for prostate cancer screening in two Korean population-based cohort studies.

Kim S, Shin C et al.

Gene

Prostate-specific antigen (PSA) levels are affected by non-cancerous conditions such as benign prost...

Prostate-specific antigen levels

Replicated

2129

Participants

N/A

Studies

Details PubMed

GWAS 2012-11-15

Impact of four loci on serum tamsulosin hydrochloride concentration.

Takata R, Matsuda K et al.

J Hum Genet

Tamsulosin hydrochloride is one of the most potent drugs for treatment of benign prostatic hyperplas...

Serum tamsulosin hydrochloride concentration

182

Participants

N/A

Studies

Details PubMed

Title

Author

Journal

Disease/Trait

Date

Actions

Genome-wide association study identifies a role for the progesterone receptor in benign prostatic hyperplasia risk.

Li W, Klein RJ

Prostate Cancer Prostatic Dis

Benign prostatic hyperplasia

2020-11-20

Heritability and genome-wide association study of benign prostatic hyperplasia (BPH) in the eMERGE network.

Hellwege JN, Stallings S et al.

Sci Rep

Benign prostatic hyperplasia

2019-04-15

Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA.

Gudmundsson J, Sigurdsson JK et al.

Nat Commun

Benign prostatic hyperplasia and lower urinary tract symptoms

2018-11-08

A genetic variant near GATA3 implicated in inherited susceptibility and etiology of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS).

Na R, Helfand BT et al.

Prostate

Benign prostatic hyperplasia and/or lower urinary tract symptoms

2017-06-28

Genetic variants at 1q32.1, 10q11.2 and 19q13.41 are associated with prostate-specific antigen for prostate cancer screening in two Korean population-based cohort studies.

Kim S, Shin C et al.

Gene

Prostate-specific antigen levels

2014-11-27

Impact of four loci on serum tamsulosin hydrochloride concentration.

Takata R, Matsuda K et al.

J Hum Genet

Serum tamsulosin hydrochloride concentration

2012-11-15